ANNE VINCENT: Open Payments
NPI 1447672464 · OREM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$939 in 39 payments from 11 companies in 2025. Trend: 2023 $923 · 2024 $796 · 2025 $939
Food & beverage: $939
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 9 | $301 |
| ABBVIE INC. | 13 | $157 |
| Astellas Pharma US Inc | 6 | $118 |
| Alkermes, Inc. | 1 | $106 |
| Braeburn Inc. | 2 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $75 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Organon LLC | 1 | $18 |
Products named: SPRAVATO, Veozah, VRAYLAR, VIVITROL, BRIXADI, CAPLYTA, QULIPTA, Auvelity.
Industry payments across UT — which companies pay providers there.
